MIR3136

Across TCGA pan-cancer cohorts, MIR3136 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR3136’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where MIR3136 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR3136 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

BLCA, STAD, and THCA are the cancer types where MIR3136 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3136 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	All	+0.567	.039	2	view →
STAD	All	All	+0.348	.042	1	view →
THCA	All	All	−0.242	.012	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR3136–BLCA

Open the BLCA breakdown →